Novel binding molecules with antitumoral activity

The present invention relates to a binding molecule that specifically binds to two different epitopes of an antigen expressed on tumor cells, wherein the binding molecule comprises: (a) a first binding (poly)peptide that specifically binds to a first epitope of said antigen expressed on tumor cells,...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Woods, Richard, Grabulovski, Dragan, Hachemi, Helen, Brack, Simon, Toller, Isabella, Bertschinger, Julian, Klupsch, Kristina, Schade, Babette, Mourlane, Frederic
Format: Patent
Sprache:eng
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator Woods, Richard
Grabulovski, Dragan
Hachemi, Helen
Brack, Simon
Toller, Isabella
Bertschinger, Julian
Klupsch, Kristina
Schade, Babette
Mourlane, Frederic
description The present invention relates to a binding molecule that specifically binds to two different epitopes of an antigen expressed on tumor cells, wherein the binding molecule comprises: (a) a first binding (poly)peptide that specifically binds to a first epitope of said antigen expressed on tumor cells, wherein said first binding (poly)peptide is a Fyn SH3-derived polypeptide; and (b) a second binding (poly)peptide that specifically binds to a second epitope of said antigen expressed on tumor cells. The present invention further relates to a nucleic acid molecule encoding the binding molecule of the invention, a vector comprising said nucleic acid molecule as well as a host cell or a non-human host transformed with said vector. The invention further relates to a method of producing a binding molecule of the invention as well as to pharmaceutical and diagnostic composition. Moreover, the present invention also relates to the binding molecule, the nucleic acid molecule, the vector or the host cell of the invention for use in the treatment of tumors.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_AU2013231488BB2</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>AU2013231488BB2</sourcerecordid><originalsourceid>FETCH-epo_espacenet_AU2013231488BB23</originalsourceid><addsrcrecordid>eNrjZDD0yy9LzVFIysxLycxLV8jNz0lNLs1JLVYozyzJUEjMK8ksKc3NL0rMUUhMLsksyyyp5GFgTUvMKU7lhdLcDCpuriHOHrqpBfnxqcUFicmpeakl8Y6hRgaGxkbGhiYWFk5ORsZEKgMA1CAtkw</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Novel binding molecules with antitumoral activity</title><source>esp@cenet</source><creator>Woods, Richard ; Grabulovski, Dragan ; Hachemi, Helen ; Brack, Simon ; Toller, Isabella ; Bertschinger, Julian ; Klupsch, Kristina ; Schade, Babette ; Mourlane, Frederic</creator><creatorcontrib>Woods, Richard ; Grabulovski, Dragan ; Hachemi, Helen ; Brack, Simon ; Toller, Isabella ; Bertschinger, Julian ; Klupsch, Kristina ; Schade, Babette ; Mourlane, Frederic</creatorcontrib><description>The present invention relates to a binding molecule that specifically binds to two different epitopes of an antigen expressed on tumor cells, wherein the binding molecule comprises: (a) a first binding (poly)peptide that specifically binds to a first epitope of said antigen expressed on tumor cells, wherein said first binding (poly)peptide is a Fyn SH3-derived polypeptide; and (b) a second binding (poly)peptide that specifically binds to a second epitope of said antigen expressed on tumor cells. The present invention further relates to a nucleic acid molecule encoding the binding molecule of the invention, a vector comprising said nucleic acid molecule as well as a host cell or a non-human host transformed with said vector. The invention further relates to a method of producing a binding molecule of the invention as well as to pharmaceutical and diagnostic composition. Moreover, the present invention also relates to the binding molecule, the nucleic acid molecule, the vector or the host cell of the invention for use in the treatment of tumors.</description><language>eng</language><subject>CHEMISTRY ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PEPTIDES ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2017</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20171207&amp;DB=EPODOC&amp;CC=AU&amp;NR=2013231488B2$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25542,76289</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20171207&amp;DB=EPODOC&amp;CC=AU&amp;NR=2013231488B2$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>Woods, Richard</creatorcontrib><creatorcontrib>Grabulovski, Dragan</creatorcontrib><creatorcontrib>Hachemi, Helen</creatorcontrib><creatorcontrib>Brack, Simon</creatorcontrib><creatorcontrib>Toller, Isabella</creatorcontrib><creatorcontrib>Bertschinger, Julian</creatorcontrib><creatorcontrib>Klupsch, Kristina</creatorcontrib><creatorcontrib>Schade, Babette</creatorcontrib><creatorcontrib>Mourlane, Frederic</creatorcontrib><title>Novel binding molecules with antitumoral activity</title><description>The present invention relates to a binding molecule that specifically binds to two different epitopes of an antigen expressed on tumor cells, wherein the binding molecule comprises: (a) a first binding (poly)peptide that specifically binds to a first epitope of said antigen expressed on tumor cells, wherein said first binding (poly)peptide is a Fyn SH3-derived polypeptide; and (b) a second binding (poly)peptide that specifically binds to a second epitope of said antigen expressed on tumor cells. The present invention further relates to a nucleic acid molecule encoding the binding molecule of the invention, a vector comprising said nucleic acid molecule as well as a host cell or a non-human host transformed with said vector. The invention further relates to a method of producing a binding molecule of the invention as well as to pharmaceutical and diagnostic composition. Moreover, the present invention also relates to the binding molecule, the nucleic acid molecule, the vector or the host cell of the invention for use in the treatment of tumors.</description><subject>CHEMISTRY</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PEPTIDES</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2017</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZDD0yy9LzVFIysxLycxLV8jNz0lNLs1JLVYozyzJUEjMK8ksKc3NL0rMUUhMLsksyyyp5GFgTUvMKU7lhdLcDCpuriHOHrqpBfnxqcUFicmpeakl8Y6hRgaGxkbGhiYWFk5ORsZEKgMA1CAtkw</recordid><startdate>20171207</startdate><enddate>20171207</enddate><creator>Woods, Richard</creator><creator>Grabulovski, Dragan</creator><creator>Hachemi, Helen</creator><creator>Brack, Simon</creator><creator>Toller, Isabella</creator><creator>Bertschinger, Julian</creator><creator>Klupsch, Kristina</creator><creator>Schade, Babette</creator><creator>Mourlane, Frederic</creator><scope>EVB</scope></search><sort><creationdate>20171207</creationdate><title>Novel binding molecules with antitumoral activity</title><author>Woods, Richard ; Grabulovski, Dragan ; Hachemi, Helen ; Brack, Simon ; Toller, Isabella ; Bertschinger, Julian ; Klupsch, Kristina ; Schade, Babette ; Mourlane, Frederic</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_AU2013231488BB23</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2017</creationdate><topic>CHEMISTRY</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PEPTIDES</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>Woods, Richard</creatorcontrib><creatorcontrib>Grabulovski, Dragan</creatorcontrib><creatorcontrib>Hachemi, Helen</creatorcontrib><creatorcontrib>Brack, Simon</creatorcontrib><creatorcontrib>Toller, Isabella</creatorcontrib><creatorcontrib>Bertschinger, Julian</creatorcontrib><creatorcontrib>Klupsch, Kristina</creatorcontrib><creatorcontrib>Schade, Babette</creatorcontrib><creatorcontrib>Mourlane, Frederic</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>Woods, Richard</au><au>Grabulovski, Dragan</au><au>Hachemi, Helen</au><au>Brack, Simon</au><au>Toller, Isabella</au><au>Bertschinger, Julian</au><au>Klupsch, Kristina</au><au>Schade, Babette</au><au>Mourlane, Frederic</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Novel binding molecules with antitumoral activity</title><date>2017-12-07</date><risdate>2017</risdate><abstract>The present invention relates to a binding molecule that specifically binds to two different epitopes of an antigen expressed on tumor cells, wherein the binding molecule comprises: (a) a first binding (poly)peptide that specifically binds to a first epitope of said antigen expressed on tumor cells, wherein said first binding (poly)peptide is a Fyn SH3-derived polypeptide; and (b) a second binding (poly)peptide that specifically binds to a second epitope of said antigen expressed on tumor cells. The present invention further relates to a nucleic acid molecule encoding the binding molecule of the invention, a vector comprising said nucleic acid molecule as well as a host cell or a non-human host transformed with said vector. The invention further relates to a method of producing a binding molecule of the invention as well as to pharmaceutical and diagnostic composition. Moreover, the present invention also relates to the binding molecule, the nucleic acid molecule, the vector or the host cell of the invention for use in the treatment of tumors.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng
recordid cdi_epo_espacenet_AU2013231488BB2
source esp@cenet
subjects CHEMISTRY
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PEPTIDES
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
title Novel binding molecules with antitumoral activity
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-12T13%3A39%3A18IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=Woods,%20Richard&rft.date=2017-12-07&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EAU2013231488BB2%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true